CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 75 filers reported holding CUE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $310,500 | -36.5% | 135,000 | +0.7% | 0.02% | -42.9% |
| Q2 2023 | $489,231 | -46.1% | 134,036 | -47.2% | 0.04% | -50.6% |
| Q1 2023 | $906,909 | -12.8% | 254,036 | -30.4% | 0.08% | +7.6% |
| Q4 2022 | $1,040,250 | -12.8% | 365,000 | -31.8% | 0.08% | -12.2% |
| Q3 2022 | $1,193,000 | -17.4% | 535,000 | -7.8% | 0.09% | -9.1% |
| Q2 2022 | $1,444,000 | -26.9% | 580,000 | +43.2% | 0.10% | -26.7% |
| Q1 2022 | $1,976,000 | -8.1% | 405,000 | +113.2% | 0.14% | +8.9% |
| Q4 2021 | $2,149,000 | +43.5% | 190,000 | +84.8% | 0.12% | +57.0% |
| Q3 2021 | $1,498,000 | -14.7% | 102,816 | -31.8% | 0.08% | -7.1% |
| Q2 2021 | $1,756,000 | -6.9% | 150,700 | -2.5% | 0.08% | +21.4% |
| Q1 2021 | $1,886,000 | +77.4% | 154,600 | +81.9% | 0.07% | +84.2% |
| Q4 2020 | $1,063,000 | – | 85,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |